The Centers for Medicare & Medicaid Services recently issued a memo clarifying its ligature risk policy, which pertains to environmental safeguards for patients at risk of harm to self or others. The agency expects to release comprehensive guidance for state survey agencies and accrediting organizations in the next six months. Meanwhile, the accrediting body or state agency has authority to determine the level of citation for ligature deficiencies based on its expert opinion, CMS said. According to the clarifying memo, the focus for a ligature “resistant” or ligature “free” environment is primarily aimed at psychiatric hospitals and units, and does not apply to non-psychiatric units of acute care hospitals.

Related News Articles

Headline
The Food and Drug Administration published a notice from Amneal Pharmaceutical that said the company is recalling two lots of its Ropivacaine Hydrochloride…
Headline
The Food and Drug Administration has identified a Class I recall of Q’Apel Medical 072 Aspiration System after the company submitted three device event reports…
Headline
The Food and Drug Administration has issued alerts for issues with certain catheters made by BD and Conavi. BD identified an increase in material fatigue…
Headline
The AHA Living Learning Network is launching the Quality Exchange, a virtual collaborative for health care quality and patient safety professionals at…
Headline
As part of the AHA's Patient Safety Initiative, a dedicated webpage features case studies showing how hospitals and health systems across the nation are…
Headline
The Food and Drug Administration has identified a Class I recall of Medtronic Aortic Root Cannulas due to a risk of unexpected loose material in the male luer…